Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rifaat Safadi

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
European Journal of Gastroenterology & Hepatology|March 15, 2019
Multiplication product of Model for End-stage Liver Disease and Donor Risk Index as predictive models of survival after liver transplantationAbed Khalaileh, Tawfik Khoury, Subhi Harkrosh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 3, 2010
Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudineRifaat Safadi, Qing Xie, Yagang Chen, et al.
Frontiers in Pharmacology|February 21, 2022
The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based StudyAsher Shafrir, Ariel A Benson, Lior H Katz, et al.
Digestive Diseases and Sciences|September 1, 2005
The relation between NOD2/CARD15 mutations and the prevalence and phenotypic heterogeneity of Crohn's disease: lessons from the Israeli Arab Crohn's disease cohortAmir Karban, Oren Atia, Eran Leitersdorf, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2004
Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trialEran Israeli, Rifaat Safadi, Alaa Melhem, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 14, 2006
Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosisAmjad Horani, Nidal Muhanna, Orit Pappo, et al.
Asian Journal of Surgery|November 18, 2018
Operative treatment of hepatic hydatid cysts: A single center experienceGad Marom, Tawfik Khoury, Samir Abu Gazla, et al.
Hepatology Communications|February 1, 2023
SARS-CoV-2 vaccine alleviates disease burden and severity in liver transplant recipients even with low antibody titersAbed Khalaileh, Ashraf Imam, Alaa Jammal, et al.
Drug Design, Development and Therapy|January 4, 2023
Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World StudyBowen Chen, Linzhi Zhang, Jiamin Cheng, et al.
Journal of Hepatology|March 7, 2006
Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSCAlaa Melhem, Nidal Muhanna, Amal Bishara, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
European Journal of Gastroenterology & Hepatology|March 15, 2019
Multiplication product of Model for End-stage Liver Disease and Donor Risk Index as predictive models of survival after liver transplantationAbed Khalaileh, Tawfik Khoury, Subhi Harkrosh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 3, 2010
Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudineRifaat Safadi, Qing Xie, Yagang Chen, et al.
Frontiers in Pharmacology|February 21, 2022
The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based StudyAsher Shafrir, Ariel A Benson, Lior H Katz, et al.
Digestive Diseases and Sciences|September 1, 2005
The relation between NOD2/CARD15 mutations and the prevalence and phenotypic heterogeneity of Crohn's disease: lessons from the Israeli Arab Crohn's disease cohortAmir Karban, Oren Atia, Eran Leitersdorf, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2004
Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trialEran Israeli, Rifaat Safadi, Alaa Melhem, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 14, 2006
Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosisAmjad Horani, Nidal Muhanna, Orit Pappo, et al.
Asian Journal of Surgery|November 18, 2018
Operative treatment of hepatic hydatid cysts: A single center experienceGad Marom, Tawfik Khoury, Samir Abu Gazla, et al.
Hepatology Communications|February 1, 2023
SARS-CoV-2 vaccine alleviates disease burden and severity in liver transplant recipients even with low antibody titersAbed Khalaileh, Ashraf Imam, Alaa Jammal, et al.
Drug Design, Development and Therapy|January 4, 2023
Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World StudyBowen Chen, Linzhi Zhang, Jiamin Cheng, et al.
Journal of Hepatology|March 7, 2006
Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSCAlaa Melhem, Nidal Muhanna, Amal Bishara, et al.
Pageof 12